Johnson & Johnson Medical Launches New 3D-Printed Titanium Spinal Implant Line with CONDUIT Interbody Platform
Sep 27, 2019 16:41
CST Updated
16:41
Synthes GmbH
Producer of Trauma and Maxillofacial Surgical Tools
Johnson & Johnson
Healthcare Product Manufacturers, Health Service Providers
Nadav Tomer, Global President of Spine at DePuy Synthes, commented, “The goal of our spine business is to focus on areas with the greatest potential to address unmet clinical needs. We are pleased that our human implant products have become the choice of surgeons.”"With the launch of our comprehensive implant program for degenerative disc disease, let us become the spinal solution that enhances patient viability, enabling every patient to receive a more advanced standard of care."
EIT Honeycomb Titanium
CONDUIT is a new series of implants manufactured using EIT Cellular Titanium, whose elastic properties are comparable to those of the trabecular tissue in the core of human bone. Each shape and size varies (partially depending on the orientation of implantation), and the center of each CONDUIT implant is designed with a lattice structure. Compared to the atypical porosity (50–90%) of natural trabecular bone, this structure gives the implant an 80% porosity. As the body heals, the organized and porous structure of the implant promotes osseointegration with natural bone.
DePuy Synthes’ CONDUIT Antibody Platform with EIT Cellular Titanium Technology. Photo provided by Johnson & Johnson Medical Devices Companies
Catheter implants are used to treat disc collapse associated with degenerative spinal diseases. Dr. Wilson Z. Ray, a neurosurgeon and spine consultant for DePuy Synthes, has direct experience using this device in both the lumbar (lower back) and cervical (neck) regions of the spine. One advantage highlighted by Dr. Ray is the visibility of the implant during postoperative monitoring. He commented, “Compared with other titanium interbody implants, this implant provides excellent visualization with minimal artifact on CT scans, facilitating early assessment of fusion.”
DePuy Synthes and Additive Manufacturing
DePuy Synthes is committed to supporting the advancement of medical additive manufacturing. Following the acquisition of EIT, the company invested €36 million through its Innovation Center in Ireland to promote the development of 3D printing materials science. The company also owns the 3D printing technology of Tissue Regeneration Systems, based in Michigan, and has established a long-term partnership with Materialise for the production of surgical guides.
Particularly for 3D-printed spinal implants, the company is competing with U.S. medical device manufacturers such as Stryker, which currently claims to have “the largest portfolio of 3D-printed implants on the market.”
Original article from China 3D Printing Network!
(Editor: China 3D Printing Network)